Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Consuelo Soldevila-Pico, M.D.
University of Florida
Principal Investigator - Donald Jensen, M.D.
Rush-Presbyterian - St. Luke's Medical Center, Chicago, IL
Principal Investigator - Michael Ishitani, M.D.
Rochester Methodist Hospital, Rochester, MN
Principal Investigator - Norah A. Terrault, M.D., MPH
University of California, San Francisco, CA
Principal Investigator - Patricia Sheiner, M.D.
Mount Sinai Medical Center, New York, NY
Principal Investigator - Rajender Reddy, M.D.
University of Miami, Miami, FL
Principal Investigator - Robert S. Brown, M.D., MPH
Columbia-Presbyterian Medical Center, New York, NY
Principal Investigator - Rolland C. Dickson, M.D.
Mayo Clinic
Principal Investigator - Terence Angtuaco, M.D.
Rush-Presbyterian - St. Luke's Medical Center, Chicago, IL
Principal Investigator - Velimir A. Luketic, M.D.
Virginia Commonwealth University, Richmond, VA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
- University of Florida
Gainesville, Florida, United States
- Mayo Clinic Jacksonville
Jacksonville, Florida, United States
- Jackson Memorial Hospital / University of Miami
Miami, Florida, United States
- Rush-Presbyterian - St. Luke'S Medical Center
Chicago, Illinois, United States
- the University of Michigan Health System
Ann Arbor, Michigan, United States
- Rochester Methodist Hospital
Rochester, Minnesota, United States
- Mount Sinai Medical Center
New York, New York, United States
- New York-Presbyterian Hospital Columbia-Presbyterian Medical Center
New York, New York, United States
- the University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
- Medical College of Virginia Commenwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 1999
- Primary completion
- 28 Feb 2002
- Completion
- 28 Feb 2002
- Last update posted
- 22 Jan 2019
- Registered enrollment
- 30
- Registry id
- NCT01421212
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.